A Medical Device Daily

Inviro Medical Devices (Atlanta) said it has entered into a new agreement with Premier Purchasing Partners (San Diego) that provides members of the Premier alliance continuing access to Inviro's portfolio of InviroSNAP! safety syringe products. Inviro's initial agreement was awarded as part of Premier's Technology Breakthroughs Program, effective May 1, 2007; the new agreement is a three-year contract effective Oct. 1, 2007.

"Since the announcement of our Breakthroughs Programs contract award in May, we have had great support from Premier management and tremendous interest from its member facilities in our InviroSNAP! range of safety syringes," said Jim Charlesworth, senior VP of sales for Inviro Medical Devices. "This new three-year contract allows us to plan for the development of a mutually beneficial, long-term relationship with Premier."

"Premier's Breakthroughs Program and contracting process provides great opportunities for small companies with truly differentiated technologies," said Gareth Clarke, CEO of Inviro. "We are delighted with this new agreement and look forward to developing significant business within the Premier organization."

Inviro engineers and markets safe medication delivery systems, including the InviroSNAP! safety syringe. During the second half of 2007, Inviro will add the InviroSTRIPE feature to its full range of safety and standard syringes. InviroSTRIPE is an integral write-on stripe that allows critical information to be recorded directly onto the syringe barrel, the company said.

"The addition of the stripe feature to InviroSNAP! safety syringes will provide Premier members with the opportunity to address two problems with one product; employee safety and syringe labeling," Clarke said. "We are confident this will provide a winning combination for Inviro Medical, Premier and its membership."

Serving 1,700 hospitals and nearly 46,500 other healthcare sites, Premier bills itself as the largest healthcare alliance in the U.S. dedicated to improving patient outcomes while safely reducing the cost of care.